OPK · Opko Health Inc
United States · RS rating 95 · As of 2026-11-03
| Price | 1.72 USD |
|---|---|
| 1-day change | +0.0% |
| RS rating (overall / 1M / 3M / 12M) | 95 / 81 / 92 / 73 |
| Stage | Advancing |
| Composite / Minervini / CANSLIM score | 54 / 77 / 85 |
| Industry group (rank) | Medical-Biomed/Biotech (154) |
| EPS growth Q/Q | +85.7% |
| Sales growth Q/Q | -2.1% |
| Distance from 52-week high | +0.6% |
| Market cap (USD) | $936.6M |